IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients ...

Increased our position in Inari Medical, Inc. due to attractive valuations for a market-leading medical device company. Inari dominates the PE market and has significant growth opportunities in both ...

Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient ...

IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from ...

Inari Medical Inc., which began in 2011, tried to prove for years it’s pioneering a new way of treating patients with blood clots in their veins. Doctors nowadays are clearly impressed, having treated ...

Sorrento Therapeutics Inc. has divulged antibody-drug conjugates comprising antibodies targeting HER2 covalently linked to exatecan through a linker. They are ...

The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

Just weeks after securing U.S. FDA approval for its flagship system to treat chronic limb-threatening ischemia (CLTI), Limflow SA kept the good news flowing to investors with the announcement of an ...

Inari Medical, Inc. (NASDAQ:NARI) is a medical device company that develops, manufactures, and markets devices for the interventional treatment of venous diseases. Its products primarily comprise ...

Okami Medical announced today that it appointed a new CEO alongside the closing of an oversubscribed $45 million financing.